Meyeon Park, MD, MAS
Associate Professor
Medicine
School of Medicine
My research focuses on patient outcomes in genetic kidney diseases including polycystic kidney disease and APOL1-mediated kidney disease. I am the medical director of the UCSF PKD Center of Excellence and principal investigator of the UCSF Cardiovascular Risk After Kidney Transplantation (CARAKTER) study.
Show full bio (34 words) Hide full bio
EDUCATION College: Harvard College Medical School: University of Pennsylvania School of Medicine Other Graduate Training: University of California, San Francisco, MAS Internal Medicine Residency: Yale-New Haven Hospital Nephrology Fellowship: University of California, San Francisco
Awards
Show all (5) Hide
- Physician Gratitude Award, National PKD Foundation, 2017
- Clinical Scientist Development Award, Doris Duke Charitable Foundation, 2015-2018
- Pilot for Junior Investigators in Basic and Clinical/Translational Sciences, UCSF CTSI, 2015-2016
- Centers of Excellence in Patient Research Pilot Award, UCSF Department of Medicine, 2014-2015
- K23 Career Development Award, NIH NIDDK, 2013-2018
Education & Training
Show all (5) Hide
- Diversity, Equity, and Inclusion Champion Training University of California 2019
- Nephrology fellowship University of California, San Francisco 2013
- M.A.S. in Clinical Research Graduate Division (Advanced Training in Clinical Research) University of California, San Francisco 2012
- Internal Medicine Residency Yale-New Haven Hospital 2009
- M.D. School of Medicine University of Pennsylvania 2006
Grants and Projects
Show all (4) Hide
- Living Donor Extended Time Outcomes (LETO) Study, NIH, 2019-2024
- (1/1) Maximizing geographic and scientific reach through a Northern California APOLLO Network: application for Clinical Center, NIH, 2017-2022
- Why do patients with cardiovascular disease develop kidney injury and disease?, NIH, 2013-2018
- Subclinical and clinical heart disease and the effect on kidney injury and diseas, NIH, 2012-2013
Publications (50)
Top publication keywords:
Kidney TransplantationKidney Failure, ChronicVentricular Dysfunction, LeftGlomerular Filtration RateRenal InsufficiencyAlbuminuriaCardiovascular DiseasesCalcium Channels, T-TypeHepatitis A Virus Cellular Receptor 1KidneyPolycystic Kidney DiseasesCreatinineAcute Kidney InjuryPolycystic Kidney, Autosomal DominantKidney Diseases, Cystic
-
All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: PRO.
Kidney360 2023 Eswarappa M, Park M -
41-Year-Old Male with Sub-Acute Encephalopathy, Seizures, and End Stage Renal Disease: A Unifying Diagnosis and Response to Therapy.
The Neurohospitalist 2023 Wais T, Ibarra KP, Sudarshana DM, Eswarappa M, Park M, Gallagher RC, Tsui B, Teixeira S, Josephson SA, Richie M -
Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative Approach.
BMC nephrology 2023 Smith J, Harris OO, Adey D, Park M -
Pharmacologic Management of Autosomal Dominant Polycystic Kidney Disease.
Advances in kidney disease and health 2023 Ackley W, Dahl NK, Park M -
Abstract P140: Potential Mediators for Cardiovascular Benefits of Novel Diabetes Medications: A Meta-Regression Analysis.
Circulation 2023 Jose M Rodriguez Valadez, Malak Tahsin, Umesh Masharani, Meyeon Park, M.G. Myriam Hunink, Joseph Yeboah, Lihua Li, Ellerie Weber, Yan Li, Asem Berkalieva, Luuk Avezaat, Wendy Max, Kirsten E …
Show all (45 more) Hide
-
Post-transplant ejection fraction and renal failure in cardiac transplant recipients: An analysis of the OPTN database.
Clinical transplantation 2022 Lai M, Aras MA, Park M -
Much Ado About Something: The Clinical Pattern of Tolvaptan-Associated Liver Injury in Participants With ADPKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2022 Postalcioglu M, Cullaro G, Park M -
871-P: Weight Change as Mediator for Cardiovascular Benefits of Novel Diabetes Medications: A Meta-Regression Analysis.
Diabetes 2022 JOSE M. RODRIGUEZ-VALADEZ, MYRIAM HUNINK, UMESH MASHARANI, JOSEPH YEBOAH, MEYEON PARK, LIHUA LI, ELLERIE WEBER, YAN LI, ASEM BERKALIEVA, WENDY MAX, KIRSTEN FLEISCHMANN, BART FERKET -
872-P: Cardiovascular Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Meta-Regression Analysis of 17 Randomized Trials.
Diabetes 2022 JOSE M. RODRIGUEZ-VALADEZ, MYRIAM HUNINK, UMESH MASHARANI, JOSEPH YEBOAH, MEYEON PARK, LIHUA LI, ELLERIE WEBER, YAN LI, ASEM BERKALIEVA, WENDY MAX, KIRSTEN FLEISCHMANN, BART FERKET -
Design and Basic Characteristics of a National Patient-Powered Registry in ADPKD.
Kidney360 2022 Hoover E, Perrone RD, Rusconi C, Benson B, Dahl NK, Gitomer B, Manelli A, Mrug M, Park M, Seliger SL, Phadnis MA, Thewarapperuma N, Watnick TJ -
Pretransplant Dialysis and Preemptive Transplant in Living Donor Kidney Recipients.
Kidney360 2022 Lai M, Gao Y, Tavakol M, Freise C, Lee BK, Park M -
The effect of kidney transplantation on left ventricular remodeling and global diastolic strain rate in end-stage renal disease.
Echocardiography (Mount Kisco, N.Y.) 2021 Lassen MCH, Qasim A, Webber A, Gao Y, Biering-Sørensen T, Park M -
Post-Transplant Cardiovascular Disease.
Clinical journal of the American Society of Nephrology : CJASN 2021 Birdwell KA, Park M -
Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients.
Journal of the National Comprehensive Cancer Network : JNCCN 2020 Atreya CE, Collisson EA, Park M, Grenert JP, Behr SC, Gonzalez A, Chou J, Maisel S, Friedlander TW, Freise CE, Shoji J, Semrad TJ, Van Ziffle J, Chin-Hong P -
Prescription patterns of opioids and non-steroidal anti-inflammatory drugs in the first year after living kidney donation: An analysis of U.S. Registry and Pharmacy fill records.
Clinical transplantation 2020 Vest LS, Sarabu N, Koraishy FM, Nguyen MT, Park M, Lam NN, Schnitzler MA, Axelrod D, Hsu CY, Garg AX, Segev DL, Massie AB, Hess GP, Kasiske BL, Lentine KL -
Development of renal cysts in a transplanted kidney.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020 Freise J, Cadwell C, Park M, Freise C -
Molecular characterization of a gastric cancer transmitted from an organ donor to four transplant recipients.
Journal of Clinical Oncology 2020 Chloe Evelyn Atreya, Meyeon Park, James P. Grenert, Spencer Behr, Amalia Gonzalez, Jonathan Chou, Samantha Maisel, Terence W. Friedlander, Chris E. Freise, Jun Shoji, Thomas John Semrad, Peter Chin-… -
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale.
Kidney international reports 2019 Freedman BI, Moxey-Mims MM, Alexander AA, Astor BC, Birdwell KA, Bowden DW, Bowen G, Bromberg J, Craven TE, Dadhania DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, … -
Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patients.
BMC nephrology 2019 Lassen MCH, Qasim AN, Biering-Sørensen T, Reeh JLT, Watnick T, Seliger SL, Chen H, Sawan MA, Nguyen D, Li Y, Hong SN, Park M -
Development and Validation of a Pragmatic Electronic Phenotype for CKD.
Clinical journal of the American Society of Nephrology : CJASN 2019 Norton JM, Ali K, Jurkovitz CT, Kiryluk K, Park M, Kawamoto K, Shang N, Navaneethan SD, Narva AS, Drawz P -
Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation.
Transplantation direct 2019 Lentine KL, Holscher CM, Naik AS, Lam NN, Segev DL, Garg AX, Axelrod D, Xiao H, Henderson ML, Massie AB, Kasiske BL, Hess GP, Hsu CY, Park M, Schnitzler MA -
Primary aldosteronism associated with a germline variant in CACNA1H.
BMJ case reports 2019 Wulczyn K, Perez-Reyes E, Nussbaum RL, Park M -
The Effect of Enlarged Kidneys on Calculated Body Mass Index Categorization in Transplant Recipients With ADPKD.
Kidney international reports 2019 Freise J, Tavakol M, Gao Y, Klein O, Lee BK, Freise C, Park M -
Subclinical metabolic and cardiovascular abnormalities in autosomal dominant polycystic kidney disease
.
Clinical nephrology 2018 Chirumamilla R, Mina D, Siyahian S, Park M -
Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2018 Weiner DE, Park M, Tighiouart H, Joseph AA, Carpenter MA, Goyal N, House AA, Hsu CY, Ix JH, Jacques PF, Kew CE, Kim SJ, Kusek JW, Pesavento TE, Pfeffer MA, Smith SR, Weir MR, Levey AS, Bostom AG -
"Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients With Cirrhosis.
Hepatology (Baltimore, Md.) 2018 Cullaro G, Park M, Lai JC -
Recurrent Renal Cysts in a Transplanted Kidney.
Annals of internal medicine 2018 Park M, Nussbaum RL -
Associations of TNFR1 with kidney function outcomes by age, gender, and baseline kidney function status: Data from the Heart and Soul Study.
Data in brief 2017 Park M, Maristany D, Huang D, Shlipak MG, Whooley M -
Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease.
BMC nephrology 2017 Tran WC, Huynh D, Chan T, Chesla CA, Park M -
Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul Study.
Atherosclerosis 2017 Park M, Maristany D, Huang D, Shlipak MG, Whooley M -
Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
Clinical journal of the American Society of Nephrology : CJASN 2017 Park M, Hsu CY, Go AS, Feldman HI, Xie D, Zhang X, Mifflin T, Waikar SS, Sabbisetti VS, Bonventre JV, Coresh J, Nelson RG, Kimmel PL, Kusek JW, Rahman M, Schelling JR, Vasan RS, Liu KD, Chronic Renal … -
Association of Peak Changes in Plasma Cystatin C and Creatinine With Death After Cardiac Operations.
The Annals of thoracic surgery 2016 Park M, Shlipak MG, Thiessen-Philbrook H, Garg AX, Koyner JL, Coca SG, Parikh CR, Translational Research Investigating Biomarker Endpoints in Acute Kidney Injury Consortium -
Associations of kidney injury markers with subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.
Clinical nephrology 2015 Park M, Shlipak MG, Vittinghoff E, Katz R, Siscovick D, Sarnak M, Lima JA, Hsu CY, Peralta CA -
Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.
Journal of the American Society of Nephrology : JASN 2015 Bansal N, Carpenter MA, Weiner DE, Levey AS, Pfeffer M, Kusek JW, Cai J, Hunsicker LG, Park M, Bennett M, Liu KD, Hsu CY -
Soluble endothelial cell selective adhesion molecule and cardiovascular outcomes in patients with stable coronary disease: A report from the Heart and Soul Study.
Atherosclerosis 2015 Park M, Kulkarni A, Beatty A, Ganz P, Regan M, Vittinghoff E, Whooley M -
Prevalence of abdominal aortic calcifications in older living renal donors and its effect on graft function and histology.
Transplant international : official journal of the European Society for Organ Transplantation 2015 Wu EH, Wojciechowski D, Chandran S, Yeh BM, Park M, Westphalen A, Wang ZJ -
Islands in the stream: the risk of kidney disease from cardiovascular disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2015 Park M -
NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Clinical journal of the American Society of Nephrology : CJASN 2015 Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M -
Relationship between kidney disease and endothelial function in peripheral artery disease.
Journal of vascular surgery 2014 Chong KC, Owens CD, Park M, Alley HF, Boscardin WJ, Conte MS, Gasper WJ, Grenon SM -
Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
American heart journal 2014 Park M, Vittinghoff E, Shlipak MG, Mishra R, Whooley M, Bansal N -
Abstract 314: Determinants of Endothelial Dysfunction in Peripheral Artery Disease: Importance of Kidney Disease.
Arteriosclerosis Thrombosis and Vascular Biology 2014 Karen C Chong, Christopher D Owens, Meyeon Park, Hugh F Alley, Michael S Conte, Warren J Gasper, Marlene Grenon -
An ACE in the hole for patients with advanced chronic kidney disease?
JAMA internal medicine 2014 Park M, Hsu CY -
Urine stability studies for novel biomarkers of acute kidney injury.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2013 Parikh CR, Butrymowicz I, Yu A, Chinchilli VM, Park M, Hsu CY, Reeves WB, Devarajan P, Kimmel PL, Siew ED, Liu KD, ASSESS-AKI Study Investigators -
Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study.
Arteriosclerosis, thrombosis, and vascular biology 2013 Park M, Vittinghoff E, Ganz P, Peralta CA, Whooley M, Shlipak MG -
Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation.
Biomarker insights 2013 Park M, Vittinghoff E, Liu KD, Shlipak MG, Hsu CY -
Associations between kidney function and subclinical cardiac abnormalities in CKD.
Journal of the American Society of Nephrology : JASN 2012 Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG, Chronic Renal Insufficiency Cohort (CRIC) Study Group -
Subclinical cardiac abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis.
Clinical journal of the American Society of Nephrology : CJASN 2012 Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, Peralta CA -
Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review.
American journal of nephrology 2010 Park M, Coca SG, Nigwekar SU, Garg AX, Garwood S, Parikh CR -
Pheochromocytoma presenting with myocardial infarction, cardiomyopathy, renal failure, pulmonary hemorrhage, and cyclic hypotension: case report and review of unusual presentations of pheochromocytoma.
Journal of clinical hypertension (Greenwich, Conn.) 2009 Park M, Hryniewicz K, Setaro JF -
Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancer.
Seminars in oncology 2006 Park M, Davidson R, Fox K